Suppr超能文献

使用喷雾干燥机制备的塞来昔布在PVP/异麦芽酮糖醇固体分散体中的异常溶解行为。

Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.

作者信息

Ghanavati Roya, Taheri Azade, Homayouni Alireza

机构信息

Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:501-511. doi: 10.1016/j.msec.2016.11.042. Epub 2016 Nov 14.

Abstract

Celecoxib is a COX II inhibitor NSAID which is used for joint pains, rheumatoid arthritis and osteoarthritis, however due to its poor water solubility it shows very low oral bioavailability. Using solid dispersion formulations is one of the most promising strategies to increase solubility of poorly water soluble drugs. The purpose of this study is dissolution enhancement of celecoxib by preparation of solid dispersions via spray drying technique using PVP and Isomalt as hydrophilic carriers. Different ratios of celecoxib, Isomalt and PVP K30 (7:3:0, 5:5:0, 3:7:0, 1:9:0 and 3:5:2, 3:2:5) were prepared from 2% hydroalcoholic solutions (70:30 ethanol:water) using spray drier. Particle size analyzing, saturation solubility, SEM, DSC, FT-IR, XRPD and dissolution studies in 0.25% SDS and 0.04M NaHPO mediums were performed. Stability of samples was also studied after a week and a month storage at 75% humidity condition. The results showed that the saturation solubility of celecoxib in solid dispersion samples is 20-30 folds higher than raw celecoxib. Similar results have been shown for dissolution studies. Solid state analyses showed glass solution state of celecoxib in PVP/Isomalt matrixes. FTIR studies exhibited the formation of hydrogen bonding between celecoxib and PVP in these samples. Spray dried celecoxib (amorphous celecoxib) without usage of carrier showed lower dissolution rate compare to its crystalline state (in 0.25% SDS dissolution medium) whilst these results is vise versa in NaPO dissolution medium. Interestingly almost all samples exhibited higher dissolution rate (in 0.25% SDS) after storage in 75% humidity. XRPD analysis demonstrated the crystallization of amorphous celecoxib after 1month storage. In general using PVP K30 and Isomalt as hydrophilic carriers could increase solubility and dissolution rate of celecoxib in solid dispersion formulations.

摘要

塞来昔布是一种环氧化酶-2(COX II)抑制剂非甾体抗炎药,用于缓解关节疼痛、治疗类风湿性关节炎和骨关节炎,然而,由于其水溶性较差,口服生物利用度非常低。使用固体分散体制剂是提高难溶性药物溶解度最有前景的策略之一。本研究的目的是通过喷雾干燥技术,以聚乙烯吡咯烷酮(PVP)和异麦芽酮糖醇作为亲水性载体,制备塞来昔布固体分散体,以提高其溶出度。采用喷雾干燥器,从2%的水醇溶液(70:30乙醇:水)中制备了不同比例的塞来昔布、异麦芽酮糖醇和PVP K30(7:3:0、5:5:0、3:7:0、1:9:0以及3:5:2、3:2:5)。对其进行了粒度分析、饱和溶解度测定、扫描电子显微镜(SEM)、差示扫描量热法(DSC)、傅里叶变换红外光谱(FT-IR)、X射线粉末衍射(XRPD)以及在0.25%十二烷基硫酸钠(SDS)和0.04M磷酸氢二钠介质中的溶出度研究。还研究了样品在75%湿度条件下储存一周和一个月后的稳定性。结果表明,塞来昔布在固体分散体样品中的饱和溶解度比原料药高20至30倍。溶出度研究也显示了类似的结果。固态分析表明塞来昔布在PVP/异麦芽酮糖醇基质中呈玻璃溶液状态。FTIR研究表明这些样品中塞来昔布与PVP之间形成了氢键。在不使用载体的情况下,喷雾干燥的塞来昔布(无定形塞来昔布)在0.25% SDS溶出介质中的溶出速率低于其结晶态,而在磷酸钠溶出介质中则相反。有趣的是,几乎所有样品在75%湿度下储存后,在0.25% SDS中的溶出速率都有所提高。XRPD分析表明,储存1个月后无定形塞来昔布发生了结晶。总体而言,使用PVP K30和异麦芽酮糖醇作为亲水性载体可以提高塞来昔布在固体分散体制剂中的溶解度和溶出速率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验